Mid-Day Breakouts Report - Wednesday, April 22nd, 2020

<<<Previous Mid Day Report	Next Mid Day Report >>>
<<<Previous After Market Report	Next After Market Report >>>

You are not logged in.
This means you CAN ONLY VIEW reports that were published prior to Monday, October 21, 2024.
You MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.

MIDDAY BREAKOUTS REPORT - WEDNESDAY, APRIL 22ND, 2020
Previous Mid Day Report Next Mid Day Report >>>

DOW 23487.31 468.43 (2.03%) | NASDAQ 8462.71 199.48 (2.41%) | S&P 500 2794.31 57.75 (2.11%)

Time of Screening : 4/22/2020 12:07:18 PM Report Released : 4/22/2020 12:31:40 PM
Price is: Above 52W High and Less Than 52W High but within 15% of the 52 Week High
Volume Is: At least 45% of 50 Day Average at the time of the screening.
More details about this report...

To View Current Notes and Data on currently Featured Stocks go to the latest
Featured Stocks Page

Symbol/Exchange Company Name Industry Group	PRICE	CHANGE (%Change)	Day High	Volume (% DAV) (50 DAV)	52 Wk Hi % From Hi	Date Featured	Price Featured	Pivot Point
Symbol/Exchange Company Name Industry Group	PRICE	CHANGE (%Change)	Day High	Volume (% DAV) (50 DAV)	52 Wk Hi % From Hi	Date Featured	Price Featured	Max Buy
NFLX - NASDAQ Netflix Inc	$422.81	-11.02 -2.54%	$433.00	12,873,762 148.03% of 50 DAV 50 DAV is 8,697,000	$449.52 -5.94%	4/13/2020	$393.60	PP = $393.62 MB = $413.30
Most Recent Note - 4/22/2020 12:18:52 PM G - Pulling back for a 2nd consecutive volume-driven loss. Reported earnings +107% on +28% sales revenues for the Mar '20 quarter versus the year ago period. Volume and volatility often increase near earnings news. Following an impressive spurt of volume-driven gains it has been repeatedly noted as extended from the previously noted base. Disciplined investors avoid chasing stocks more than +5% above the prior high or pivot point. See the latest FSU analysis for more details and an annotated graph. >>> The latest Featured Stock Update with an annotated graph appeared on 4/21/2020. Click here.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M

Symbol - Exchange - Industry Group Company Name	Last	Chg	Day High	52 WK Hi	% From Hi	Volume % DAV	DAV
ACU - AMEX - HEALTH SERVICES - Medical Instruments & Supplies Acme United Corp	$21.78	+0.21 0.97%	$22.71	$24.92	-12.62%	6,171 47.47%	13,000
Most Recent Note for ACU - 4/22/2020 12:08:15 PM Rebounding above its 50 and 200 DMA lines with recent gains. The past 3 quarterly comparisons through Mar '20 showed earnings increases above the +25% minimum guideline (C criteria) with sales revenues growth rate showing acceleration. Annual earnings (A criteria) history has been up and down, not a match with the fundamental guidelines of the fact-based investment system.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
AGI - NYSE - Mining-Gold/Silver/Gems Alamos Gold Inc	$7.37	+0.78 11.76%	$7.42	$7.78	-5.33%	2,392,348 57.30%	4,175,000
Most Recent Note for AGI - 4/22/2020 12:09:27 PM Gapped up today and challenging its 52-week high. The 4/14/20 mid-day report cautioned members - "Earnings history is not a match with the fact-based investment system's fundamental guidelines."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
AKG - AMEX - Mining-Gold/Silver/Gems Asanko Gold Inc	$1.21	+0.11 10.00%	$1.22	$1.12	8.04%	582,243 112.84%	516,000
Most Recent Note for AKG - 4/22/2020 12:10:15 PM Gapped up today hitting a new 52-week high and adding to a recent spurt of volume-driven gains. Fundamentals are sub par.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
DRD - NYSE - METALS & MINING - Gold Drdgold Ltd Adr	$9.01	+0.52 6.12%	$9.14	$9.69	-7.02%	380,961 89.01%	428,000
Most Recent Note for DRD - 4/22/2020 12:10:49 PM Held its ground stubbornly after spiking to a new 52-week high with a big volume-driven gain on 4/13/20. Found prompt support near its 200 DMA line in recent weeks. Recent quarterly comparisons through Dec '19 showed greatly improved sales revenues and strong earnings increases versus year ago losses. Fundamental concerns remain as when noted with caution in the 2/07/13 mid-day report - "This low-priced South African company in the Mining - Gold/Silver/Gems group has an erratic earnings history, not a match with the fact-based investment system's guidelines."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
GFI - NYSE - METALS & MINING - Gold Gold Fields Ltd Adr	$7.05	+0.51 7.72%	$7.13	$7.90	-10.82%	5,406,136 52.45%	10,308,000
Most Recent Note for GFI - 4/22/2020 12:11:19 PM Rebounding toward multi-year highs. The 4/14/20 mid-day report cautioned - "This South African company in the Mining - Gold/Silver/Gems industry has shown erratic sales revenues and earnings history through the Dec '19 quarter. Up and down annual earnings (A criteria) history is a fundamental concern."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
HLI - NYSE - Finance-Invest Bnk/Bkrs Houlihan Lokey Inc	$61.19	+4.35 7.65%	$62.24	$59.91	2.14%	361,037 67.99%	531,000
Most Recent Note for HLI - 4/22/2020 12:13:41 PM Gapped up today hitting a new all-time high. Fundamental concerns remain, as it reported earnings +14% on +12% sales revenues for the Dec '19 quarter, and prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria). It was dropped from the Featured Stocks list on 3/28/18. Completed a new Public Offering on 3/12/18.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
INFU - AMEX - Medical-Services Infusystem Holdings Inc	$12.83	-0.07 -0.57%	$13.25	$13.04	-1.64%	45,969 47.88%	96,000
Most Recent Note for INFU - 4/22/2020 12:15:01 PM Hitting new highs after a deep "V" shaped consolidation, not an orderly base. Recent quarterly comparisons through Dec '19 showed improved earnings versus losses for the year ago periods. Annual earnings history has been erratic, not a match with the fact-based investment system's fundamental guidelines.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
IPHI - NYSE - Elec-Semicondctor Fablss Inphi Corp	$95.03	+0.76 0.80%	$99.11	$99.46	-4.46%	2,444,539 229.32%	1,066,000
Most Recent Note for IPHI - 4/22/2020 12:16:41 PM Churning heavy volume while hovering near its all-time high after recent gains lacking great volume conviction. Reported Dec '19 earnings +4% on a +19% increase in sales revenues versus the year ago period. Fundamental concerns remain due to its erratic quarterly and annual earnings (C and A criteria) history.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
KGC - NYSE - METALS & MINING - Gold Kinross Gold Corp	$6.69	+0.49 7.82%	$6.76	$6.64	0.68%	11,805,616 46.45%	25,414,000
Most Recent Note for KGC - 4/22/2020 12:17:36 PM Hitting another new 52-week high with today's gap up. The 3 latest quarters through Dec '19 showed accelerating sales revenues and earnings increases. Prior mid-day reports cautioned members - "Quarterly and annual earnings (C and A criteria) history is not a match with the fact-based investment system's fundamental guidelines."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
NOMD - NYSE - Food-Packaged Nomad Foods Ltd	$20.96	+0.24 1.16%	$21.21	$23.06	-9.11%	1,043,213 64.52%	1,617,000
Most Recent Note for NOMD - 4/22/2020 12:19:57 PM Rebounding above its 200 DMA line toward prior highs in the $22-23 area where it previously met stubborn resistance. Prior mid-day reports noted - "Reported earnings +9% on +0% sales revenues for the Dec '19 quarter. Prior earnings and sales revenues growth was not strong and steady."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
ODC - NYSE - CHEMICALS - Specialty Chemicals Oil Dri Corp America	$34.90	+0.70 2.05%	$35.11	$38.80	-10.05%	17,075 85.38%	20,000
Most Recent Note for ODC - 4/22/2020 12:22:01 PM Recently inching back above its 50 and 200 DMA lines. Earnings increases have been strong in quarterly comparisons through Jan '20. Sub par sales revenues growth is not a match with the fact-based investment system's fundamental guidelines. Up and down annual earnings (A criteria) history.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
OSUR - NASDAQ - DRUGS - Diagnostic Substances Orasure Technologies Inc	$14.66	+1.22 9.09%	$14.67	$14.50	1.11%	637,126 62.65%	1,017,000
Most Recent Note for OSUR - 4/22/2020 12:23:03 PM Hitting yet another new 52-week high today, adding to an impressive rebound from the March low ($5.23). Prior mid-day reports repeatedly noted - "Quarterly and annual earnings history (C and A criteria) is not a match with the fundamental guidelines of the fact-based investment system."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
PLMR - NASDAQ - INSURANCE - Property & Casualty Insurance Palomar Holdings Inc	$60.45	+5.29 9.59%	$62.32	$65.55	-7.78%	190,155 62.35%	305,000
Most Recent Note for PLMR - 4/22/2020 12:24:45 PM Consolidating after hitting a new all-time high with a volume-driven gain on 4/20/20. Found support near its 200 DMA line during the consolidation since completing a new Public Offering on 1/10/20. Reported earnings +140% on +121% sales revenues for the Dec '19 quarter. Limited history is a concern. Completed its $15 IPO on 4/17/19.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
QDEL - NASDAQ - DRUGS - Diagnostic Substances Quidel Corp	$118.68	+5.74 5.08%	$120.97	$113.94	4.16%	333,374 58.80%	567,000
Most Recent Note for QDEL - 4/22/2020 12:26:40 PM Spiking to new all-time highs with recent gains lacking great volume conviction. This San Diego, CA based maker of rapid diagnostic tests for infectious diseases has earned a high Earnings Per Share rating of 95. Reported earnings +23% on +15% sales revenues for the Dec '19 quarter and prior quarterly earnings comparisons were below the +25% minimum guideline (C criteria). Annual earnings (A criteria) history include a slight downturn in FY '19 following strong earnings growth in FY '17 and '18.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
RVP - AMEX - HEALTH SERVICES - Medical Instruments & Supplies Retractable Technologies	$2.94	+0.17 6.14%	$3.10	$3.45	-14.78%	244,187 61.98%	394,000
Most Recent Note for RVP - 4/22/2020 12:28:04 PM Perched near its 52-week high following a recent spurt of volume-driven gains. Prior mid-day reports noted - "Prior quarterly and annual earnings (C and A criteria) history is not a match with the fact-based investment system's fundamental guidelines."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
SLP - NASDAQ - COMPUTER SOFTWARE & SERVICES - Business Software & Services Simulations Plus Inc	$42.49	+2.48 6.20%	$42.91	$41.95	1.29%	90,405 57.22%	158,000
Most Recent Note for SLP - 4/22/2020 12:29:18 PM Hitting a new all-time high with today's 3rd consecutive gain. Prior mid-day reports noted - "Reported earnings +0% on +22% sales revenues for the Feb '20 quarter versus the year-ago period and fundamental concerns remain. Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria). Quarterly sales revenues totals have been in the $6-10 million range, growing, but still rather minuscule for publicly traded companies. Has a new CEO effective 6/26/18."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
USNA - NYSE - DRUGS - Drug Related Products U S A N A Health Science	$80.64	+11.76 17.07%	$81.77	$93.43	-13.69%	298,464 123.33%	242,000
Most Recent Note for USNA - 4/22/2020 12:31:37 PM Gapped up today. Reported Mar '20 earnings +22% on -2% sales revenues. Prior quarterly comparisons weak earnings increases well below the +25% minimum guideline (C criteria) while sales revenues have been waning.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M

THESE ARE NOT BUY RECOMMENDATIONS! Comments contained in the body of this report are technical opinions only. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. We are not an investment advisor, hence it does not endorse or recommend any securities or other investments. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. All trademarks, service marks and trade names appearing in this report are the property of their respective owners, and are likewise used for identification purposes only.

This report is a service available only to active Paid Premium Members. You may opt-out of receiving report notifications at any time. Questions or comments may be submitted by writing to FactBasedInvesting.com c/o Premium Member Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.

We appreciate any feedback members may wish to send via the inquiry form here.